Louisiana State Employees Retirement System’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-19,500
Closed -$3.59M 1521
2025
Q4
$3.59M Sell
19,500
-1,900
-9% -$333K 0.06% 263
2025
Q3
$3.28M Sell
21,400
-400
-2% -$60.5K 0.06% 286
2025
Q2
$3.05M Buy
21,800
+550
+3% +$77.1K 0.06% 298
2025
Q1
$3.12M Hold
21,250
0.06% 253
2024
Q4
$2.78M Sell
21,250
-950
-4% -$133K 0.05% 312
2024
Q3
$3.46M Sell
22,200
-950
-4% -$153K 0.06% 249
2024
Q2
$3.61M Buy
23,150
+300
+1% +$45.1K 0.07% 213
2024
Q1
$3.1M Sell
22,850
-300
-1% -$39.7K 0.06% 268
2023
Q4
$3.12M Buy
23,150
+100
+0.4% +$13K 0.06% 237
2023
Q3
$3.12M Buy
23,050
+4,550
+25% +$621K 0.07% 211
2023
Q2
$2.65M Buy
18,500
+3,500
+23% +$515K 0.06% 268
2023
Q1
$2.08M Sell
15,000
-200
-1% -$26.9K 0.05% 329
2022
Q4
$2.06M Sell
15,200
-700
-4% -$87.8K 0.06% 319
2022
Q3
$1.74M Buy
15,900
+400
+3% +$50.7K 0.05% 358
2022
Q2
$2.11M Buy
15,500
+300
+2% +$39.4K 0.06% 287
2022
Q1
$2.09M Buy
+15,200
New +$1.82M 0.05% 355

Other funds holding AZN

Louisiana State Employees Retirement System's AZN Position: Q1 2026 in Review

Louisiana State Employees Retirement System sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 19,500 shares — an estimated $3.59M sold.

Louisiana State Employees Retirement System first reported a position in AZN in Q1 2022 and held it in 16 quarters. The position peaked at $3.61M in Q2 2024. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Louisiana State Employees Retirement System reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Louisiana State Employees Retirement System sold 19,500 AstraZeneca shares in Q1 2026, an estimated $3.59M.
  • Louisiana State Employees Retirement System first reported a position in AstraZeneca in Q1 2022 and held it in 16 quarters.
  • Louisiana State Employees Retirement System's AstraZeneca position peaked at $3.61M in Q2 2024.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Louisiana State Employees Retirement System's 13F filing for Q1 2026, filed 20 Apr 2026.